PRESS RELEASE published on 10/28/2024 at 12:56, 1 year 11 months ago EQS-Adhoc: ESPG AG announces reorganisation concept and decides to submit the corresponding restructuring plan to the competent local court in accordance with StaRUG ESPG AG announces reorganisation plan under German StaRUG law, involving capital reduction and new shareholders for restructuring. ReCapCo and BondCo provide liquidity Reorganisation ESPG AG Capital Reduction StaRUG New Shareholders
PRESS RELEASE published on 10/28/2024 at 12:45, 1 year 11 months ago Stillwater Critical Minerals Enters Letter of Intent to Sell the Duke Island Cu-Ni-PGE Project in Alaska to Granite Creek Copper Stillwater Critical Minerals Corp. announces a Letter of Intent with Granite Creek Copper for the acquisition of a 90% interest in the Duke Island Cu-Ni-PGE project Acquisition Stillwater Critical Minerals Letter Of Intent Granite Creek Copper Duke Island
PRESS RELEASE published on 10/28/2024 at 12:45, 1 year 11 months ago Granite Creek Expands Portfolio with Alaska Ultramafic Acquisitions and Partners with Cornell University to Study Geologic Hydrogen Potential under Department of Energy Grant Granite Creek Copper Ltd. acquires Alaskan projects rich in critical minerals, collaborating with Dr. Gadikota of Cornell University to explore geologic hydrogen production Critical Minerals Granite Creek Copper Geologic Hydrogen Production Cornell University Alaskan Projects
PRESS RELEASE published on 10/28/2024 at 12:30, 1 year 11 months ago Hardman & Co Q&A on NB Private Equity Partners: The unique value of co-investment in private equity Hardman & Co Research presents a Q&A on NB Private Equity Partners focusing on the value of co-investment in private equity, discussing expertise, long-term returns, deal flow, partnerships, and risk management Private Equity Hardman & Co Research Interview NB Private Equity Partners Co-investment
PRESS RELEASE published on 10/28/2024 at 12:30, 1 year 11 months ago MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain MIRA Pharmaceuticals announces promising preclinical results for Ketamir-2, a potential breakthrough therapy surpassing current treatments. Study shows 60% greater efficacy than gabapentin in reducing chemotherapy-induced pain, to be presented at Pain Therapeutics Summit Pain Management Preclinical Results MIRA Pharmaceuticals Ketamir-2 Breakthrough Therapy
PRESS RELEASE published on 10/28/2024 at 12:30, 1 year 11 months ago George Mason University Team Develops Successful Augmented Reality Campus Tour for Transfer Students Using ARway.ai ARway.ai announces extension of augmented reality app project at George Mason University into 2025 after achieving significant milestones. The initiative supports first-generation ADVANCE students with cutting-edge AR technology ARway.ai Augmented Reality AR Technology George Mason University First-Generation Students
PRESS RELEASE published on 10/28/2024 at 12:30, 1 year 11 months ago Grid Battery Metals Update - Drilling Completed on its Clayton Valley Lithium Project Grid Battery Metals Inc. completes drilling at Silver Peak, Clayton Valley, Nevada. Strategic land package adjacent to Albemarle's ponds and Century Lithium Corp.'s mine. Lithium assay results expected in November Exploration Drilling Program Grid Battery Metals Inc. Lithium Nevada
PRESS RELEASE published on 10/28/2024 at 12:30, 1 year 11 months ago ZTEST Electronics Inc. Announces Record Revenues and Net Income for Fiscal 2024 ZTEST Electronics Inc. reports impressive fiscal 2024 results: 250% revenue growth, net income up 961%, EPS increase of 867%. CEO Steve Smith highlights investments in technology for future success Revenue Growth Fiscal 2024 Net Income ZTEST Electronics Inc. CEO Steve Smith
PRESS RELEASE published on 10/28/2024 at 12:26, 1 year 11 months ago Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
PRESS RELEASE published on 10/28/2024 at 12:11, 1 year 11 months ago Funding Circle Plc: NOG-Notice of GM Funding Circle Holdings plc announces a General Meeting on 14 Nov 2024 for shareholder approval of Proposed Capital Reduction. Full details on their website Shareholder Approval Circular General Meeting Funding Circle Holdings Proposed Capital Reduction
Published on 10/19/2026 at 14:30, 5 hours 18 minutes ago Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 5 hours 48 minutes ago Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 6 hours 18 minutes ago Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 6 hours 18 minutes ago Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 6 hours 47 minutes ago CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Published on 10/19/2026 at 19:00, 48 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Published on 10/19/2026 at 18:05, 1 hour 43 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 2 hours 3 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:45, 2 hours 3 minutes ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Published on 10/19/2026 at 17:30, 2 hours 18 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 19/10/2026
Published on 10/19/2026 at 19:00, 48 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Published on 10/19/2026 at 18:40, 1 hour 8 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:40, 1 hour 8 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Published on 10/19/2026 at 18:00, 1 hour 48 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 1 hour 48 minutes ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola